Amundi
DTIL icon

Amundi’s Precision BioSciences DTIL Stock Holding History

Amundi’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,521
Closed -$78K – 2159
2024
Q3 		$78K Hold
8,521
– – ﹤0.01% 1799
2024
Q2 		$79.1K Hold
8,521
– – ﹤0.01% 1736
2024
Q1 		$91.3K Hold
8,521
– – ﹤0.01% 1777
2023
Q4 		$112K Buy
+8,521
New +$91.9K ﹤0.01% 1754

Other funds holding DTIL

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Amundi's DTIL Position: Q4 2024 in Review

Amundi sold out of Precision BioSciences (DTIL) in Q4 2024, closing a stake of 8,521 shares — an estimated $78K sold.

Amundi first reported a position in DTIL in Q4 2023 and held it in 4 quarters. The position peaked at $112K in Q4 2023. 55 funds tracked by Wall St. Rank hold DTIL as of Q4 2024.

  • Amundi reported no remaining Precision BioSciences position as of Q4 2024 after selling out during the quarter.
  • Amundi sold 8,521 Precision BioSciences shares in Q4 2024, an estimated $78K.
  • Amundi first reported a position in Precision BioSciences in Q4 2023 and held it in 4 quarters.
  • Amundi's Precision BioSciences position peaked at $112K in Q4 2023.
  • 55 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2024.

Based on Amundi's 13F filing for Q4 2024, filed 7 Feb 2025.